XT
OKUR

XTX Topco’s OnKure Therapeutics OKUR Stock Holding History

XTX Topco’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$141K Buy
34,129
+16,328
+92% +$50.4K ﹤0.01% 2983
2025
Q4 		$51.6K Buy
+17,801
New +$53.3K ﹤0.01% 2825
2025
Q3 		– Sell
-10,643
Closed -$25.4K – 3457
2025
Q2 		$25.4K Buy
+10,643
New +$27.9K ﹤0.01% 2131
2025
Q1 		– Sell
-18,633
Closed -$160K – 3255
2024
Q4 		$160K Buy
+18,633
New +$282K 0.01% 1639

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

XTX Topco's OKUR Position: Q1 2026 in Review

XTX Topco increased its OnKure Therapeutics (OKUR) stake by 92% in Q1 2026, buying an estimated $50.4K and bringing the position to 34,129 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #2983.

XTX Topco first reported a position in OKUR in Q4 2024 and has held it in 4 quarters since. The position peaked at $160K in Q4 2024. 51 funds tracked by Wall St. Rank hold OKUR as of Q1 2026.

  • XTX Topco held 34,129 shares of OnKure Therapeutics worth $141K as of Q1 2026.
  • XTX Topco bought 16,328 OnKure Therapeutics shares in Q1 2026, an estimated $50.4K.
  • OnKure Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #2983 holding.
  • XTX Topco first reported a position in OnKure Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • XTX Topco's OnKure Therapeutics position peaked at $160K in Q4 2024.
  • 51 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.